Results from a recent study have the potential to inform treatment and care strategies for individuals with type 2 diabetes mellitus and cardiovascular disease diagnosed with COVID-19. June 6, 2022 9:00 AM Eastern Daylight Time WILMINGTON, Del. – (BUSINESS WIRE) – COVID-19 patients with both type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) showed […]
Read More
WILMINGTON, Del., Aug. 23, 2021 – HealthCore, Inc. has been awarded a Top Workplaces 2021 honor by The News Journal. The list is based solely on feedback from all employees, across all locations, and gathered through an anonymous third-party survey that measures 15 drivers of engaged cultures that are critical to the success of any […]
Read More
WILMINGTON, Del. – August 19, 2021 Dr. Stephan Lanes, a Principal Scientist at HealthCore, has been named a 2021 Fellow of the International Society for Pharmacoepidemiology. ISPE Fellowship is awarded to members who demonstrate seniority, scholarship through quality and impact of publications, service to ISPE, and leadership in pharmacoepidemiology. Dr. Lanes is one of ten […]
Read More
WILMINGTON, Del. – July 15, 2021 – HealthCore, Inc., the independently operating research subsidiary of Anthem, Inc., is celebrating 25 years of finding evidence and truth at the core of healthcare. “HealthCore has been pushing to transform healthcare industry evidentiary standards for 25 years,” said Mark Cziraky, president and co-founder of HealthCore. “We changed the […]
Read More
HealthCore Evolution Drives Better Data Alignment for Customers WILMINGTON, Del. — Feb. 2, 2021 — Mark Cziraky, former vice president of scientific affairs, chief growth officer, and co-founder of HealthCore, Inc. has become president of HealthCore while Marcus Wilson, former president and co-founder, now leads the Enterprise Analytics Hub, a new division of Anthem, […]
Read More
HealthCore Coordinating First US Longitudinal Study to Understand New COVID-19 Pediatric Syndrome With Greater Impact on Black and Latino Children November 16, 2020 09:00 AM Eastern Standard Time WILMINGTON, Del.–(BUSINESS WIRE)–HealthCore, an outcomes research company of Anthem, Inc., is managing a new study to help understand and combat the pediatric public health emergency arising from […]
Read More
THE NEWS JOURNAL NAMES HEALTHCORE A WINNER OF THE DELAWARE TOP WORKPLACES 2020 AWARD WILMINGTON, Del., Aug. 24, 2020 – HealthCore, Inc. has been awarded a Top Workplaces 2020 honor by The News Journal. The list is based solely on employee feedback gathered through an anonymous third-party survey that measures 15 drivers of engaged cultures […]
Read More
Accompanying editorial calls for further refinements in value-based insurance design to reduce unintended use of low-value care, reports the latest issue of The American Journal of Managed Care®. May 14, 2019 10:40 AM Eastern Daylight Time CRANBURY, N.J.–(BUSINESS WIRE)–When a large national employer removed cost sharing for primary care visits, medical utilization fell, as did […]
Read More
January 23, 2019 – At more than $54 billion, spending to treat all orthopedic pain conditions (including pain in the muscles, bones and joints) represents more than 14 percent of overall healthcare spending for commercially insured adult Blue Cross Blue Shield (BCBS) members.1,2 This report identifies trends in cost and quality of care for elective […]
Read More
Real-world study compares Ozempic® (semaglutide) to other standard diabetes therapies October 17, 2018 09:00 AM Eastern Daylight Time WILMINGTON, Del.–(BUSINESS WIRE)–HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. (NYSE: ANTM) and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind […]
Read More